v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Previously Reported
Series Quantum Preferred Stock
Previously Reported
Common Stock
Previously Reported
Common Stock to be Issued
Previously Reported
Additional Paid-In Capital
Previously Reported
Non-Controlling Interest
Previously Reported
Accumulated Other Comprehensive Income
Previously Reported
Accumulated Deficit
Previously Reported
Series Quantum Preferred Stock
Common Stock
Common Stock to be Issued
Additional Paid-In Capital
Non-Controlling Interest
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balances at Dec. 31, 2023                 $ 4,202 $ 30,948,057 $ (221,886) $ (31,062,852) $ (332,479)
Balances (in Shares) at Dec. 31, 2023                 42,017,948          
Proceeds from sale of common stock                 $ 1,500 148,540 150,040
Proceeds from sale of common stock (in Shares)                 15,000,000          
Issuance of common stock for liabilities                 $ 363 353,328 353,691
Issuance of common stock for liabilities (in Shares)                 3,631,354          
Common and preferred stock issued for cash                 $ 100 $ 505 1,014,350 1,014,955
Common and preferred stock issued for cash (in Shares)                 1,000,000 5,050,000          
Stock-based compensation                 $ 200,000 1,164,951,000 1,165,151,000
Stock-based compensation (in Shares)                 2,000,000          
Net income (loss)               $ (3,270,544) (3,270,544) (3,270,544)
Balances at Dec. 31, 2024 $ 100 $ 6,770 $ 33,629,226 $ (221,886) $ (34,333,396) (919,186) $ 7,000 33,629,000 (222,000) (34,333,000) (919,000)
Balances (in Shares) at Dec. 31, 2024 1,000,000 67,699,302           1,000,000 67,699,302          
Stock-based compensation                 416,000 416,000
Stock-based compensation (in Shares)                          
Net income (loss)                 (660,000) (660,000)
Balances at Mar. 31, 2025                 $ 7,000 34,045,000 (222,000) (34,993,000) (1,163,000)
Balances (in Shares) at Mar. 31, 2025                 1,000,000 67,699,302          
Balances at Dec. 31, 2024 $ 100 $ 6,770 33,629,226 (221,886) (34,333,396) (919,186) $ 7,000 33,629,000 (222,000) (34,333,000) (919,000)
Balances (in Shares) at Dec. 31, 2024 1,000,000 67,699,302           1,000,000 67,699,302          
Stock-based compensation                 1,077,319 1,077,319
Stock-based compensation (in Shares)                 214          
Common stock issued pursuant to business combination                 $ 800 12,879,200 12,880,000
Common stock issued pursuant to business combination (in Shares)                 8,000,000          
Common stock issued pursuant to private placement                 $ 149 1,834,821 1,834,970
Common stock issued pursuant to private placement (in Shares)                 1,494,700          
Common stock to be issued pursuant to business combination               3,407,250 $ 3,407,250 3,407,250
Common stock to be issued pursuant to business combination (in Shares)                 1,500,000          
Common stock issued pursuant to assets purchase agreement                 $ 900 19,709,100 19,710,000
Common stock issued pursuant to assets purchase agreement (in Shares)                 9,000,000          
Common stock issued pursuant to debt settlement                 $ 1 9,999 10,000
Common stock issued pursuant to debt settlement (in Shares)                 10,000          
Common stock issued pursuant to services                 $ 205 4,427,295 4,427,500
Common stock issued pursuant to services (in Shares)                 2,050,000          
Settlement of related party liabilities               675,700 $ (100) 675,800 675,700
Settlement of related party liabilities (in Shares)                 (1,000,000)          
Net income (loss)               918,355 132,551 918,355 1,050,906
Balances at Dec. 31, 2025 $ 8,825 $ 3,407,250 74,242,760 (221,886) 132,551 (33,415,041) 44,154,459 $ 9,000 $ 3,407,000 74,243,000 (222,000) 133,000 (33,415,000) 44,155,000
Balances (in Shares) at Dec. 31, 2025 88,254,216 1,500,000           88,254,216 1,500,000          
Stock-based compensation                 275,000 275,000
Stock-based compensation (in Shares)                          
Common stock issued pursuant to business combination                 $ 0 $ (2,272,000) 2,272,000
Common stock issued pursuant to business combination (in Shares)                 1,000,000 (1,000,000)          
Common stock issued pursuant to private placement                 $ 0 200,000 200,000
Common stock issued pursuant to private placement (in Shares)                 100,000          
Net income (loss) $ (87,000) $ (9,405,000) $ (9,492,000)               (9,405,000)
Balances at Mar. 31, 2026                 $ 9,000 $ 1,135,000 $ 76,990,000 $ (222,000) $ 46,000 $ (42,820,000) $ 35,138,000
Balances (in Shares) at Mar. 31, 2026                 89,354,216 500,000